Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

newline pharma, s.l. - dexamethasone phosphate - eye drops, solution in single-dose container - 1.37 milligram(s)/millilitre - dexamethasone

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroids use in certain infective conjunctivides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/enteroba

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - tobramycin and dexamethasone ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - tobramycin and dexamethasone ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

exelan pharmaceuticals, inc. - difluprednate (unii: s8a06qg2qe) (difluprednate - unii:s8a06qg2qe) - difluprednate ophthalmic emulsion 0.05%, a topical corticosteroid, is indicated for the treatment of inflammation and pain associated with ocular surgery. difluprednate ophthalmic emulsion is also indicated for the treatment of endogenous anterior uveitis. the use of difluprednate ophthalmic emulsion, as with other ophthalmic corticosteroids, is contraindicated in most active viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal disease of ocular structures. teratogenic effects pregnancy category c. difluprednate has been shown to be embryotoxic (decrease in embryonic body weight and a delay in embryonic ossification) and teratogenic (cleft palate and skeletal anomalies) when administered subcutaneously to rabbits during organogenesis at a dose of 1-10 mcg/kg/day. the no-observed-effect-level (noel) for these effects was 1 mcg/kg/day, and 10 mcg/kg/day was considered t

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

armas pharmaceuticals inc. - loteprednol etabonate (unii: yeh1ez96k6) (loteprednol - unii:z8cbu6kr16) - loteprednol etabonate is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation. loteprednol etabonate is less effective than prednisolone acetate 1% in two 28-day controlled clinical studies in acute anterior uveitis, where 72% of patients treated with loteprednol etabonate experienced resolution of anterior chamber cells, compared to 87% of patients treated with prednisolone acetate 1%. the incidence of patients with clinically significant increases in iop (≥10 mmhg) was 1% with loteprednol etabonate and 6% with prednisolone acetate 1%. loteprednol etabonate should not be used in patients who require a more potent corticosteroid for this indi

Ֆիլիպիններ - անգլերեն - FDA (Food And Drug Administration)

amb hk enterprises inc.; distributor: amb hk enterprises inc. - multivitamins , minerals - effervescent tablet - each effervescent tablet contains: ascorbic acid nicotinamide (vitamin b3) pantothenic acid (vitamin b5) thiamine hydrochloride (vitamin b1) riboflavin (vitamin b2) pyridoxine hydrochloride (vitamin b6) 500mg 50mg 23mg folic acid (vitamin b9) biotin (vitamin h) cyanocobalamin (vitamin b12) calcium (as calcium carbonate and calcium pantothenate) magnesium (as magnesium carbonate heavy and magnesium sulfate dehydrate) zinc (as zinc citrate trihydrate) 400mcg 150mcg 10mcg 100mg 100mg 10mg 15mg 10mg

Բանգլադեշ - անգլերեն - DGDA (Directorate General of Drug Administration)

globex pharmaceuticals ltd. - ascorbic acid + biotin + boron + calcium + chromium + copper + cyanocobalamin + elemental iron + folic acid + iodine + lutein + magnesium + manganese + molybdenum + niacin + nickel + pantothenic acid + phosphorous + pottassium + pyridoxine hydrochloride + riboflavin + selenium + silicon + tin + vanadium + vitamin a + vitamin b1 + vitamin d3 + vitamin e + vitamin k + zinc - tablet - 60 mg + 30 mcg + 150 mcg + 162 mg + 120 mcg + 2 mg + 6 mcg + 18 mg + 400 mcg + 150 mcg + 250 mcg + 100 mg + 2 mg + 75 mcg + 20 mg + 5 mcg + 10 mg + 109 mg + 80 mg + 2 mg + 1.7 mg + 20 mcg + 2 mg + 10 mcg + 10 mcg + 5000 iu + 1.5 mg + 400 iu + 30 iu + 25 mcg + 15 mg

Բանգլադեշ - անգլերեն - DGDA (Directorate General of Drug Administration)

globex pharmaceuticals ltd. - boron + calcium + copper + magnesium + manganese + vitamin d + zinc - tablet - 250 mcg + 600 mg + 1 mg + 40 mg + 1.8 mg + 200 iu + 7 mg

Բանգլադեշ - անգլերեն - DGDA (Directorate General of Drug Administration)

globex pharmaceuticals ltd. - nicotinamide + pyridoxine hydrochloride + riboflavin + vitamin b1 + zinc - syrup - 400 mg + 40 mg + 50 mg + 100 mg + 200 mg/100 ml